Filtrer vos résultats
- 2
- 1
- 2
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trialthe 41st ESMO Congress (ESMO 2016), the European Society for Medical Oncology, Oct 2016, Copenhague, Denmark. pp.456O, ⟨10.1093/annonc/mdw370.5⟩
Communication dans un congrès
hal-01490996v1
|
|||
|
Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in FranceClinical Microbiology and Infection, 2016, 22 (8), pp.737.e9-737.e15. ⟨10.1016/j.cmi.2016.05.025⟩
Article dans une revue
hal-02290969v1
|
||
|
Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in FranceClinical Microbiology and Infection, 2016, 22 (8), pp.737.e9--737.e15. ⟨10.1016/j.cmi.2016.05.025⟩
Article dans une revue
hal-01398377v1
|